Cellectis S A : and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
#cellectis
#sanofi
3 years ago By Yoongi — May 11, 2021 - Paris - Cellectis S.A. (NASDAQ: CLLS - Euronext Growth: ALCLS), a clinical-stage biotechnological company employing its core proprietary tec